Enoxaparin Becat Laboratorios Farmacéuticos Rovi

Enoxaparin Sodium is an anticoagulant medication used to prevent and treat blood clots. It is commonly administered via subcutaneous or intravenous routes, including during haemodialysis.

Enoxaparin Sodium is primarily used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to prevent blood clots in patients undergoing certain medical procedures or those who are bedridden. This medication works by thinning the blood, making it harder for clots to form. It is often prescribed for patients undergoing haemodialysis to maintain the patency of the dialysis circuit.

Common effects of Enoxaparin Sodium may include bruising, bleeding, and pain at the injection site. Some users may experience nausea, headache, or dizziness. Severe allergic reactions are rare but can occur. It is important to monitor for signs of unusual bleeding or bruising.

Enoxaparin Sodium should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to follow the prescribed dosage and administration instructions carefully. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Enoxaparin Sodium can interact with other medications that affect blood clotting, such as aspirin, warfarin, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can increase the risk of bleeding. Patients should also be cautious when using medications that affect liver enzymes, as this can alter the effectiveness of Enoxaparin Sodium.